Tazarotene

FDA Approved: * April 3, 2017
Pharm Company: * TARO
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Tazarotene Overview

Tazarotene (marketed as Tazorac, Avage, Zorac, and Fabior) is a third-generation prescription topical retinoid sold as a cream, gel, or foam. Tazarotene is a member of the acetylenic class of retinoids. This medication is approved for treatment of psoriasis, acne, and sun damaged skin (photodamage). It is commonly sold in two concentrations: 0.05% and 0.1%. Contents 1 Mechanism of action 2 Side effects 3 Uses 4 Synthesis 5 Notes Mechanism of action Tazarotene is a retinoid prodrug w...

Read more Tazarotene Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tazarotene

Recent Tazarotene Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Tazarotene
  • Aerosol, Foam: 0.1%
  • Cream: 0.05%, 0.1%, 0.10%
  • Foam: 0.1%
  • Gel: 0.05%, 0.1%, 0.10%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Tazarotene: (6 results)

Sorted by National Drug Code
  • 0023-9236 Avage 1 mg/g Cutaneous Cream by Allergan, Inc.
  • 0713-0670 Tazarotene 1 mg/g Topical Cream by G&w Laboratories, Inc.
  • 51672-1373 Tazarotene 1 mg/g Topical Cream by Taro Pharmaceuticals U.S.a., Inc.
  • 51672-1374 Tazarotene 1 mg/g Topical Cream by Taro Pharmaceuticals U.S.a., Inc.
  • 60758-556 Tazarotene .5 mg/g Topical Cream by Pacific Pharma, Inc.
  • 60758-561 Tazarotene 1 mg/g Topical Cream by Pacific Pharma, Inc.

Other drugs which contain Tazarotene or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA